《盈警響號》亞太資源(01104.HK)料年度盈轉虧 蝕4億至4.8億元
亞太資源(01104.HK)公布,截至今年6月30日止年度預期將錄得虧損介乎於4億元至4.8億元,相比去年同期為溢利約13.57億元。
轉虧主要由於上年度就集團於澳洲證交所上市之主要聯營公司MGX,而錄得的一間聯營公司之權益之減值虧損撥回約5.8億元不會在2022年度再次發生。此外,集團於2022年度於MGX之投資錄得減值虧損;資源投資分部於2022年度錄得的溢利較2021年度減少;及相比2021年度分佔聯營公司溢利為約1.32億元,主要由於2022年度MGX的虧損,導致2022年度錄得分佔聯營公司及一間合營公司淨虧損。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.